You
are here: Home: CCU 1 | 2003: Mace
L Rothenberg, MD: Select publications
Select publications regarding oxaliplatin in
metastatic colorectal cancer
Becouarn Y et al. Randomized multicenter phase II
study comparing a combination of fluorouracil and folinic
acid and alternating irinotecan and oxaliplatin with oxaliplatin
and irinotecan in fluorouracil-pretreated metastatic colorectal
cancer patients. J Clin Oncol 2001;19(22):4195-201.
Abstract
Cassinello J et al. Multicenter phase II study of
oxaliplatin (OXA) every two weeks in combination with weekly
5-FU bolus and folicic acid (FA) as first line treatment for
advanced colorectal cancer (ACC). Proc ASCO 2002;
Abstract
2244.
Chau I et al. Oxaliplatin and protracted venous
infusion of 5-fluorouracil in patients with advanced or relapsed
5-fluorouracil pretreated colorectal cancer. Br J
Cancer 2001;85(9):1258-64. Abstract
Giacchetti S et al. First line infusion of 5-fluorouracil,
leucovorin, oxaliplatin for metastatic colorectal cancer chronomodulated
versus conventional delivery. A multicenter randomized trial
of the EORTC chronotherapy group. Proc ASCO 2002;
Abstract
2231.
Goldberg RM et al. N9741: Oxaliplatin (oxal) or
CPT-11 + 5-fluorouracil (5FU)/leucovorin (LV) or oxal + CPT-11
in advanced colorectal cancer (CRC). Initial toxicity and
response data from a GI Intergroup study. Proc ASCO
2002; Abstract
511.
Grothey A et al. Phase III study of bolus 5-fluorouracil
(5-FU)/ folinic acid (FA) (Mayo) vs weekly high-dose 24h 5-FU
infusion/ FA + oxaliplatin (OXA) (FUFOX) in advanced colorectal
cancer (ACRC). Proc ASCO 2002; Abstract
512.
Levi F et al. Age-independent benefit of chronotherapy
with 5-fluorouracil, leucovorin and oxaliplatin in patients
with metastatic colorectal cancer within multicenter randomized
phase III trials. Proc ASCO 2002; Abstract
1431.
Ravaioli A et al. Bolus fluorouracil and leucovorin
with oxaliplatin as first-line treatment in metastatic colorectal
cancer. J Clin Oncol 2002;20(10):2545-50. Abstract
Zori Comba A et al. A randomised phase II study
of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil
and folinic acid (Mayo Clinic regimen) in previously untreated
metastatic colorectal cancer patients. Eur J Cancer
2001;37(8):1006-13. Abstract
|
